- Home
- ASTC vs NERV Comparison
ASTC vs NERV Comparison
Compare ASTC & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- NERV
- Stock Information
- Founded
- ASTC 1984
- NERV 2007
- Country
- ASTC United States
- NERV United States
- Employees
- ASTC N/A
- NERV N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- NERV Health Care
- Exchange
- ASTC Nasdaq
- NERV Nasdaq
- Market Cap
- ASTC 9.9M
- NERV 12.4M
- IPO Year
- ASTC 1995
- NERV 2014
- Fundamental
- Price
- ASTC $5.82
- NERV $1.54
- Analyst Decision
- ASTC
- NERV Hold
- Analyst Count
- ASTC 0
- NERV 1
- Target Price
- ASTC N/A
- NERV $5.00
- AVG Volume (30 Days)
- ASTC 2.9K
- NERV 7.8K
- Earning Date
- ASTC 05-13-2025
- NERV 05-13-2025
- Dividend Yield
- ASTC N/A
- NERV N/A
- EPS Growth
- ASTC N/A
- NERV N/A
- EPS
- ASTC N/A
- NERV 0.83
- Revenue
- ASTC $903,000.00
- NERV N/A
- Revenue This Year
- ASTC N/A
- NERV N/A
- Revenue Next Year
- ASTC N/A
- NERV N/A
- P/E Ratio
- ASTC N/A
- NERV $1.86
- Revenue Growth
- ASTC N/A
- NERV N/A
- 52 Week Low
- ASTC $5.75
- NERV $1.15
- 52 Week High
- ASTC $12.29
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- ASTC 45.48
- NERV 48.69
- Support Level
- ASTC $5.75
- NERV $1.48
- Resistance Level
- ASTC $6.12
- NERV $1.55
- Average True Range (ATR)
- ASTC 0.15
- NERV 0.12
- MACD
- ASTC 0.01
- NERV 0.00
- Stochastic Oscillator
- ASTC 17.52
- NERV 54.55
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.